ARAMIS BIOTECHNOLOGIES Trademark

Trademark Overview


On Thursday, September 5, 2024, a trademark application was filed for ARAMIS BIOTECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the ARAMIS BIOTECHNOLOGIES trademark a serial number of 79410370. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, September 25, 2025. This trademark is owned by Biotechnologies Aramis inc.. The ARAMIS BIOTECHNOLOGIES trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacture of pharmaceuticals, pharmaceutical ingredients and human vaccines, custom manufacturing of pharmaceuticals, pharmaceutical ingredients and human vaccines.

Pharmaceutical and medicinal preparations and substances, namely, vaccines; pharmaceutical and medicinal preparations and substances, namely, recombinant proteins in the nature of pharmaceutical preparations for the treatment and prevention of infectious diseases

Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines; on-line health information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines

Research and development in the field of human vaccines; high-throughput vaccine engineering services; medical and scientific research services in the field of recombinant protein platform technologies for new human vaccines; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients and human vaccines; medical and scientific research in the field of clinical trial studies on new vaccine candidates for others
aramis biotechnologies

General Information


Serial Number79410370
Word MarkARAMIS BIOTECHNOLOGIES
Filing DateThursday, September 5, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, September 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 14, 2025

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals, pharmaceutical ingredients and human vaccines, custom manufacturing of pharmaceuticals, pharmaceutical ingredients and human vaccines.
Description of MarkThe mark consists of the stylized wording "ARAMIS" with a leaf incorporated as part of the "i". Below is the stylized wording "BIOTECHNOLOGIES".
Goods and ServicesPharmaceutical and medicinal preparations and substances, namely, vaccines; pharmaceutical and medicinal preparations and substances, namely, recombinant proteins in the nature of pharmaceutical preparations for the treatment and prevention of infectious diseases
Goods and ServicesMedical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines; on-line health information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines
NOT AVAILABLE"BIOTECHNOLOGIES"
Goods and ServicesResearch and development in the field of human vaccines; high-throughput vaccine engineering services; medical and scientific research services in the field of recombinant protein platform technologies for new human vaccines; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients and human vaccines; medical and scientific research in the field of clinical trial studies on new vaccine candidates for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiotechnologies Aramis inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events


Event DateEvent Description
Thursday, November 21, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, November 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 24, 2024APPLICATION FILING RECEIPT MAILED
Friday, March 7, 2025ASSIGNED TO EXAMINER
Sunday, March 9, 2025NON-FINAL ACTION WRITTEN
Monday, March 10, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 15, 2025REFUSAL PROCESSED BY MPU
Tuesday, April 15, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, May 4, 2025REFUSAL PROCESSED BY IB
Tuesday, September 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER